Azione 300497 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Jiangxi Fushine Pharmaceutical Co., Ltd.

Azioni

300497

CNE1000024Z7

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 08/07/2024 		Variaz. 5gg Var. 1 gen.
8,5 CNY -3,41% Grafico intraday di Jiangxi Fushine Pharmaceutical Co., Ltd. -6,90% -9,19%
28/04 Jiangxi Fushine Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
28/04 Jiangxi Fushine Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Fushine Pharma's Unit Gets Nod for Tazobactam Sodium
Jiangxi Fushine Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding
Fushine Pharmaceutical's Unit Gets Nod to Market Antidepressant
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jiangxi Fuxiang Pharma to Invest 32.5 Million Yuan in New Biotechnology Unit
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Fuxiang Pharma's Profit to Rise in H1
Fuxiang Pharma’s Vice Chairman, Deputy General Manager to Boost Shareholding
Fushine Pharma Earmarks 386 Million Yuan to Build New Chemical Factory
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.
Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 4, 2021, has expired with 11,355,900 shares, representing 2.09% for CNY 174.83 million.
LinkChem Co., Ltd. announced that it has received CNY 117 million in funding from Jiangxi Fushine Pharmaceutical Co., Ltd.
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300497
  4. Notizie Jiangxi Fushine Pharmaceutical Co., Ltd.
  5. Altre lingue